Results 251 to 258 of about 74,852 (258)

Making the best of PARP inhibitors in ovarian cancer

Nature Reviews Clinical Oncology, 2010
Susana Banerjee, Stan B Kaye, Banerjee Susana   +2 more
exaly  

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer

Cancer Cell, 2016
Marina A Bellani, Ying Zou, Zeba N Singh   +2 more
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Nicolas Sayegh, Jennifer K Litton   +2 more
exaly  

On the Way to Selective PARP‐2 Inhibitors. Design, Synthesis, and Preliminary Evaluation of a Series of Isoquinolinone Derivatives

ChemMedChem, 2008
Emidio Camaioni, Laura Formentini, Francesco Venturoni   +2 more
exaly  

Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold

Bioorganic Chemistry, 2019
Ghada F Elmasry, Fadi M Awadallah, Samir M El-Moghazy   +2 more
exaly  

PARP inhibitors in ovarian cancer: Current status and future promise

Gynecologic Oncology, 2014
Joyce F Liu, Panagiotis A Konstantinopoulos, Ursula A Matulonis   +2 more
exaly  

PARP inhibitors for prostate cancer

Seminars in Oncology
Nick Beije, Johann S de Bono
exaly  

Design, synthesis and antitumor activities of phthalazinone derivatives as PARP-1 inhibitors and PARP-1/HDAC-1 inhibitors

Bioorganic Chemistry
Ping Gong
exaly